$COLL
Collegium Pharmaceutical Inc

2024 Q4 Form 10-Q Financial Statement

#000155837024014858 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $159.3M
YoY Change 16.53%
Cost Of Revenue $62.51M
YoY Change 10.83%
Gross Profit $96.79M
YoY Change 20.52%
Gross Profit Margin 60.76%
Selling, General & Admin $61.96M
YoY Change 75.52%
% of Gross Profit 64.01%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $61.96M
YoY Change 75.52%
Operating Profit $34.84M
YoY Change -22.6%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $15.58M
YoY Change -45.87%
Income Tax $6.245M
% Of Pretax Income 40.08%
Net Earnings $9.335M
YoY Change -54.76%
Net Earnings / Revenue 5.86%
Basic Earnings Per Share $0.29
Diluted Earnings Per Share $0.27
COMMON SHARES
Basic Shares Outstanding 32.25M 32.21M
Diluted Shares Outstanding 40.16M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $120.0M
YoY Change -60.61%
Cash & Equivalents $38.96M
Short-Term Investments $81.00M
Other Short-Term Assets
YoY Change
Inventory $38.03M
Prepaid Expenses
Receivables $228.5M
Other Receivables
Total Short-Term Assets $443.8M
YoY Change -17.37%
LONG-TERM ASSETS
Property, Plant & Equipment $14.61M
YoY Change -12.2%
Goodwill $146.0M
YoY Change 9.04%
Intangibles $946.9M
YoY Change 107.55%
Long-Term Investments
YoY Change
Other Assets $4.171M
YoY Change 463.65%
Total Long-Term Assets $1.191B
YoY Change 86.0%
TOTAL ASSETS
Total Short-Term Assets $443.8M
Total Long-Term Assets $1.191B
Total Assets $1.635B
YoY Change 38.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.142M
YoY Change -13.99%
Accrued Expenses $47.60M
YoY Change 50.39%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $459.4M
YoY Change -1.12%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $459.4M
Total Long-Term Liabilities
Total Liabilities $1.401B
YoY Change 40.27%
SHAREHOLDERS EQUITY
Retained Earnings -$176.5M
YoY Change -33.42%
Common Stock $40.00K
YoY Change 5.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $234.3M
YoY Change
Total Liabilities & Shareholders Equity $1.635B
YoY Change 38.86%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $9.335M
YoY Change -54.76%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 coll Fair Value Liabilities Level1 To Level2 Transfers Amount1
FairValueLiabilitiesLevel1ToLevel2TransfersAmount1
0
CY2024Q3 coll Fair Value Liabilities Level1 To Level2 Transfers Amount1
FairValueLiabilitiesLevel1ToLevel2TransfersAmount1
0
CY2023Q3 coll Fair Value Assets Level2 To Level1 Transfers Amount1
FairValueAssetsLevel2ToLevel1TransfersAmount1
0
CY2024Q3 coll Fair Value Assets Level2 To Level1 Transfers Amount1
FairValueAssetsLevel2ToLevel1TransfersAmount1
0
CY2023Q3 coll Fair Value Liabilities Level2 To Level1 Transfers Amount1
FairValueLiabilitiesLevel2ToLevel1TransfersAmount1
0
CY2024Q3 coll Fair Value Liabilities Level2 To Level1 Transfers Amount1
FairValueLiabilitiesLevel2ToLevel1TransfersAmount1
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2023Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2024#ProductMember
us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2024#ProductMember
CY2024Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2024#ProductMember
CY2023Q3 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2024#ProductMember
us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2024#ProductMember
CY2024Q3 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2024#ProductMember
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2024#ProductMember
us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2024#ProductMember
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001267565
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37372
dei Entity Registrant Name
EntityRegistrantName
Collegium Pharmaceutical, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
VA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
03-0416362
dei Entity Address Address Line1
EntityAddressAddressLine1
100 Technology Center Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Stoughton
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02072
dei City Area Code
CityAreaCode
781
dei Local Phone Number
LocalPhoneNumber
713-3699
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
COLL
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32250236
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38960000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
238947000
CY2024Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
80997000
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
71601000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
228456000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
179525000
CY2024Q3 us-gaap Inventory Net
InventoryNet
38032000
CY2023Q4 us-gaap Inventory Net
InventoryNet
32332000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32365000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15195000
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
25000000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
443810000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
537600000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14614000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15983000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6169000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6029000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
946875000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
421708000
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1047000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1047000
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
72509000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
26259000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4171000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
825000
CY2024Q3 us-gaap Goodwill
Goodwill
145959000
CY2023Q4 us-gaap Goodwill
Goodwill
133857000
CY2024Q3 us-gaap Assets
Assets
1635154000
CY2023Q4 us-gaap Assets
Assets
1143308000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3142000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8692000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
47600000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
37571000
CY2024Q3 coll Accrued Rebates Returns And Discounts Current
AccruedRebatesReturnsAndDiscountsCurrent
313874000
CY2023Q4 coll Accrued Rebates Returns And Discounts Current
AccruedRebatesReturnsAndDiscountsCurrent
227331000
CY2024Q3 us-gaap Loans Payable Current
LoansPayableCurrent
64583000
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
183333000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1271000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
988000
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
28956000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
459426000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
457915000
CY2024Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
565716000
CY2023Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
221713000
CY2024Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
236911000
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
262125000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5914000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6124000
CY2024Q3 coll Deferred Royalty Liability Non Current
DeferredRoyaltyLiabilityNonCurrent
118812000
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
10000000
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
4096000
CY2024Q3 us-gaap Liabilities
Liabilities
1400875000
CY2023Q4 us-gaap Liabilities
Liabilities
947877000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39616456
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32230016
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38192441
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31868549
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
40000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
38000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
582762000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
565949000
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
7386440
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6323892
CY2024Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
172381000
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
137381000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
393000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
14000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-176535000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-233189000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
234279000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
195431000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1635154000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1143308000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
159301000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
136709000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
449500000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
417022000
CY2024Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
21706000
CY2023Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
20081000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
60611000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
74237000
CY2024Q3 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
40801000
CY2023Q3 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
36317000
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
109833000
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
111246000
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
62507000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
56398000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
170444000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
185483000
CY2024Q3 us-gaap Gross Profit
GrossProfit
96794000
CY2023Q3 us-gaap Gross Profit
GrossProfit
80311000
us-gaap Gross Profit
GrossProfit
279056000
us-gaap Gross Profit
GrossProfit
231539000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
61955000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
35298000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
147272000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
126266000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
61955000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
35298000
us-gaap Operating Expenses
OperatingExpenses
147272000
us-gaap Operating Expenses
OperatingExpenses
126266000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
34839000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
45013000
us-gaap Operating Income Loss
OperatingIncomeLoss
131784000
us-gaap Operating Income Loss
OperatingIncomeLoss
105273000
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
18394000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
20768000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
51320000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
64058000
CY2024Q3 us-gaap Investment Income Net
InvestmentIncomeNet
3280000
CY2023Q3 us-gaap Investment Income Net
InvestmentIncomeNet
4538000
us-gaap Investment Income Net
InvestmentIncomeNet
12164000
us-gaap Investment Income Net
InvestmentIncomeNet
11312000
CY2024Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4145000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-11329000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-23504000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15580000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
28783000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
81299000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29023000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6245000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8149000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24645000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12808000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
9335000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
20634000
us-gaap Net Income Loss
NetIncomeLoss
56654000
us-gaap Net Income Loss
NetIncomeLoss
16215000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.61
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.75
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32259468
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33744209
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32339401
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34226488
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.53
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.51
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40163266
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42058821
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40400483
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35149154
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
9335000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
20634000
us-gaap Net Income Loss
NetIncomeLoss
56654000
us-gaap Net Income Loss
NetIncomeLoss
16215000
CY2024Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
575000
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-14000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
379000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-52000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
575000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-14000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
379000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-52000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9910000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20620000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
57033000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
16163000
us-gaap Profit Loss
ProfitLoss
56654000
us-gaap Profit Loss
ProfitLoss
16215000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
109833000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
111246000
us-gaap Depreciation
Depreciation
2815000
us-gaap Depreciation
Depreciation
2547000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-16658000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1815000
us-gaap Share Based Compensation
ShareBasedCompensation
24804000
us-gaap Share Based Compensation
ShareBasedCompensation
20134000
coll Operating Lease Payments Non Cash
OperatingLeasePaymentsNonCash
-67000
coll Operating Lease Payments Non Cash
OperatingLeasePaymentsNonCash
-258000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4592000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
6672000
coll Noncash Interest Expense For Deferred Royalty Liability
NoncashInterestExpenseForDeferredRoyaltyLiability
473000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-11329000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-23504000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1652000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
667000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4520000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1268000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-11455000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-12376000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12122000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-42000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-12088000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
106000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-61952000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4479000
coll Increase Decrease In Accrued Rebates Returns And Discounts
IncreaseDecreaseInAccruedRebatesReturnsAndDiscounts
7440000
coll Increase Decrease In Accrued Rebates Returns And Discounts
IncreaseDecreaseInAccruedRebatesReturnsAndDiscounts
14520000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
120336000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
201411000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
267538000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1082000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
297000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
84003000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
51418000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
76626000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
6000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-275997000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45715000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
827000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
460000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10073000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5401000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
18891000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
8128000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
35000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
50000000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
91667000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
116667000
coll Payments Of Term Note Modification Fees
PaymentsOfTermNoteModificationFees
11825000
coll Proceeds From Term Note Modification
ProceedsFromTermNoteModification
313175000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
6280000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
235220000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
138638000
coll Repurchase Of Convertible Notes Including Premium And Fees
RepurchaseOfConvertibleNotesIncludingPremiumAndFees
33245000
us-gaap Repayments Of Assumed Debt
RepaymentsOfAssumedDebt
164598000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19326000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-72352000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-174987000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
83344000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
239994000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
176235000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65007000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
259579000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38960000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
258532000
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
26047000
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1047000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65007000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
259579000
us-gaap Interest Paid Net
InterestPaidNet
47210000
us-gaap Interest Paid Net
InterestPaidNet
57679000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
51469000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
17293000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
53000
coll Noncash Or Part Noncash Acquisition Contingent Consideration
NoncashOrPartNoncashAcquisitionContingentConsideration
4096000
us-gaap Business Combination Consideration Transferred Liabilities Incurred
BusinessCombinationConsiderationTransferredLiabilitiesIncurred
28956000
us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
coll Returns Policy Threshold Product Return Period
ReturnsPolicyThresholdProductReturnPeriod
P18M
coll Returns Policy Threshold Product Return Period Prior To Expiration
ReturnsPolicyThresholdProductReturnPeriodPriorToExpiration
P6M
coll Returns Policy Threshold Product Return Period After Expiration
ReturnsPolicyThresholdProductReturnPeriodAfterExpiration
P12M
coll Returns Policy Threshold Product Return Period
ReturnsPolicyThresholdProductReturnPeriod
P18M
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
159301000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
136709000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
449500000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
417022000
coll Contract With Customer Upfront Payment
ContractWithCustomerUpfrontPayment
10000000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
25000000
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
25000000
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P7Y8M12D
CY2024Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
178899000
CY2023Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
157805000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
512925000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
474725000
CY2024Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
5390000
CY2023Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
11567000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
35969000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
102849000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
9335000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
20634000
us-gaap Net Income Loss
NetIncomeLoss
56654000
us-gaap Net Income Loss
NetIncomeLoss
16215000
CY2024Q3 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
1416000
CY2023Q3 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
1645000
us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
4358000
CY2024Q3 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
10751000
CY2023Q3 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
22279000
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
61012000
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
16215000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32259468
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33744209
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32339401
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34226488
CY2024Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
6606305
CY2023Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
7509104
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
6606305
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40163266
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42058821
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40400483
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35149154
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.61
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.75
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.53
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.51
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2023Q3 coll Fair Value Assets Level1 To Level2 Transfers Amount1
FairValueAssetsLevel1ToLevel2TransfersAmount1
0
CY2024Q3 coll Fair Value Assets Level1 To Level2 Transfers Amount1
FairValueAssetsLevel1ToLevel2TransfersAmount1
0
CY2024Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
93954000
CY2024Q3 coll Contingent Consideration Fair Value Disclosure
ContingentConsiderationFairValueDisclosure
4096000
CY2024Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
4096000
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
153629000
CY2024Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
80997000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
76330000
CY2024Q3 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
80604000
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
404000
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
11000
CY2024Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
80997000
CY2023Q4 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
76316000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
59000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
45000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
76330000
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
42392000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
61672000
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
38605000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
14658000
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
80997000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
76330000
coll Sale Of Marketable Securities
SaleOfMarketableSecurities
0
CY2024Q3 coll Sale Of Marketable Securities
SaleOfMarketableSecurities
0
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
4203000
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
10384000
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
17389000
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
6740000
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
16440000
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
15208000
CY2024Q3 us-gaap Inventory Net
InventoryNet
38032000
CY2023Q4 us-gaap Inventory Net
InventoryNet
32332000
CY2024Q3 us-gaap Goodwill
Goodwill
145959000
CY2023Q4 us-gaap Goodwill
Goodwill
133857000
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1586170000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
639295000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
946875000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
951170000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
529462000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
421708000
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
40801000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
36317000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
109833000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
111246000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
55471000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
221891000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
194199000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
91114000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
91114000
CY2024Q3 coll Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
293086000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
946875000
CY2024Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
7397000
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
4987000
CY2024Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
7185000
CY2023Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
14198000
CY2024Q3 coll Accrued Product Taxes And Fees Current
AccruedProductTaxesAndFeesCurrent
4906000
CY2023Q4 coll Accrued Product Taxes And Fees Current
AccruedProductTaxesAndFeesCurrent
5013000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4332000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1511000
CY2024Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
3542000
CY2023Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
1198000
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3163000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
700000
CY2024Q3 coll Accrued Liability For Cash Settled Share Based Awards Assumed From Acquiree Current
AccruedLiabilityForCashSettledShareBasedAwardsAssumedFromAcquireeCurrent
3044000
CY2024Q3 coll Accrued Payables For Inventory Current
AccruedPayablesForInventoryCurrent
2415000
CY2024Q3 coll Accrued Incentive Compensation Current
AccruedIncentiveCompensationCurrent
2255000
CY2023Q4 coll Accrued Incentive Compensation Current
AccruedIncentiveCompensationCurrent
1375000
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
1943000
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
2853000
CY2024Q3 coll Accrued Severance Expense Related To Acquisition Current
AccruedSeveranceExpenseRelatedToAcquisitionCurrent
1501000
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1066000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2136000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4851000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3600000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
47600000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
37571000
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
26350000
CY2024Q3 coll Deferred Royalty Obligation Interest Rate Effective Percentage
DeferredRoyaltyObligationInterestRateEffectivePercentage
0.152
CY2024Q3 coll Deferred Royalty Liability Non Current
DeferredRoyaltyLiabilityNonCurrent
118339000
CY2024Q3 coll Deferred Royalty Accretion Interest Expense
DeferredRoyaltyAccretionInterestExpense
473000
CY2024Q3 coll Deferred Royalty Liability Non Current
DeferredRoyaltyLiabilityNonCurrent
118812000
coll Interest Expense On Deferred Royalty Liability
InterestExpenseOnDeferredRoyaltyLiability
1526000
CY2024Q3 coll Interest Expense On Deferred Royalty Liability
InterestExpenseOnDeferredRoyaltyLiability
1526000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
195431000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4205000
CY2024Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
356000
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000
CY2024Q1 coll Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units And Performance Share Units Value
StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsAndPerformanceShareUnitsValue
-12874000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7475000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-138000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
27713000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
222169000
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5728000
CY2024Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000
CY2024Q2 coll Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units Value
StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsValue
-5875000
CY2024Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
35000000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10012000
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-58000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
19606000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
216583000
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
140000
CY2024Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
471000
CY2024Q3 coll Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units Value
StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsValue
-142000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7317000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
575000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
9335000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
234279000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
194842000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3848000
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
169000
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000
CY2023Q1 coll Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units And Performance Share Units Value
StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsAndPerformanceShareUnitsValue
-7736000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6035000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-17426000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
179733000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1251000
CY2023Q2 coll Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units Value
StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsValue
-220000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7072000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-38000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
13007000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
200805000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
302000
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
291000
CY2023Q3 coll Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units Value
StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsValue
-172000
CY2023Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
40000000
CY2023Q3 coll Adjustments To Additional Paid In Capital Forward Contract On Share Repurchase Agreement
AdjustmentsToAdditionalPaidInCapitalForwardContractOnShareRepurchaseAgreement
10000000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7027000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-14000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
20634000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
178873000
CY2023Q4 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
922775
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7317000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7027000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24804000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20134000
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
54165000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y3M18D
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6245000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8149000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24645000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12808000
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.401
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.283
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.303
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.441

Files In Submission

Name View Source Status
0001558370-24-014858-index-headers.html Edgar Link pending
0001558370-24-014858-index.html Edgar Link pending
0001558370-24-014858.txt Edgar Link pending
0001558370-24-014858-xbrl.zip Edgar Link pending
coll-20240930.xsd Edgar Link pending
coll-20240930x10q.htm Edgar Link pending
coll-20240930x10q001.jpg Edgar Link pending
coll-20240930xex31d1.htm Edgar Link pending
coll-20240930xex31d2.htm Edgar Link pending
coll-20240930xex32d1.htm Edgar Link pending
coll-20240930xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
coll-20240930_cal.xml Edgar Link unprocessable
coll-20240930_def.xml Edgar Link unprocessable
coll-20240930_lab.xml Edgar Link unprocessable
coll-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
coll-20240930x10q_htm.xml Edgar Link completed
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending